Dr. Eitan S. Burstein, MD

Dr. Burstein practices at Danbury Eye Physicians & Surgeons in Danbury, Connecticut.

Dr. Burstein's NPI, 1558621656, was assigned on May 22, 2012. Dr. Burstein graduated from State University of New York Downstate Medical Center in 2012. Dr. Burstein holds Connecticut license 56255.

Dr. Burstein's primary practice is Danbury Eye Physicians & Surgeons, at 69 Sandpit Rd, Danbury, CT 06810 in Western Ct County. The practice phone is (203) 791-2020.

Dr. Burstein's primary practice is Danbury Eye Physicians & Surgeons in Danbury, Connecticut. Dr. Burstein is also affiliated with Saint Mary's Hospital. Dmand AI also links Dr. Burstein to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Burstein practices, 2 sites in all. Vendor and product names are available with a free account.

Glaucoma specialist is Dr. Burstein's primary specialty in the NPI Registry, under taxonomy code 207WX0009X. Dr. Burstein is licensed in Connecticut.

CMS data shows 2,625 Medicare services from Dr. Burstein across 18 procedure codes in 2024, for 693 Medicare patients. Medicare paid $216,983 for them.

CMS counts 693 Medicare patients who saw Dr. Burstein in 2024. The largest group is 75 to 84, with 265 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Burstein's median patient age at 72, with 55% women.

In 2024, Dr. Burstein wrote 3,260 Medicare Part D claims for 936 patients. 54% of them were for generic drugs. CMS names the drug for 3,119 of them, across 23 drugs with 11 or more claims each, at $384,986 in total drug cost. In 2023, CMS named 3,321 claims across 27 drugs.

Dr. Burstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 229 procedures of cataract surgery by Dr. Burstein, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Burstein, published from 2013 to 2020. Dr. Burstein has published most often in Clin Ophthalmol. Dr. Burstein's most frequent co-authors are Peter A. Netland, MD, Asima Bajwa, MD and Douglas R. Lazzaro, MD.

CMS Open Payments shows 155 general payments to Dr. Burstein from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. Valeant Pharmaceuticals International paid the most, $1,476. It also lists 11 research payments totaling $1,902 in 2024, naming 1 clinical trial.

Dr. Burstein graduated from State University of New York Downstate Medical Center in 2012.